Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neuroone Medical Technologies (NMTC) Non Operating Income (2020 - 2025)

Neuroone Medical Technologies (NMTC) has disclosed Non Operating Income for 8 consecutive years, with $19058.0 as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Non Operating Income fell 38.54% year-over-year to $19058.0, compared with a TTM value of $77062.0 through Mar 2025, down 15.44%, and an annual FY2024 reading of $125179.0, up 30.72% over the prior year.
  • Non Operating Income was $19058.0 for Q1 2025 at Neuroone Medical Technologies, up from $9408.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $83387.0 in Q2 2021 and bottomed at -$26909.0 in Q1 2023.
  • Average Non Operating Income over 4 years is $25336.0, with a median of $24298.0 recorded in 2024.
  • Peak annual rise in Non Operating Income hit 215.23% in 2024, while the deepest fall reached 79.36% in 2024.
  • Year by year, Non Operating Income stood at $83387.0 in 2021, then tumbled by 45.35% to $45575.0 in 2023, then tumbled by 79.36% to $9408.0 in 2024, then soared by 102.57% to $19058.0 in 2025.
  • Business Quant data shows Non Operating Income for NMTC at $19058.0 in Q1 2025, $9408.0 in Q4 2024, and $22220.0 in Q3 2024.